Table 4.
Fibrinolysis (n=99) | Angioplasty (n=103) | p Value | |
Primary end points at 30 days | |||
Death | 12 (12.1%) | 8 (7.8%) | 0.30 |
Reinfarction | 2 (2.0%) | 3 (2.9%) | 1.00 |
Composite (death + reinfarction) | 14 (14.1%) | 11 (10.7%) | 0.46 |
Other cardiac events at 30 days | |||
Angina | 11 (11.1%) | 3 (2.9%) | 0.027 |
Heart failure | 14 (14.1%) | 19 (18.4%) | 0.41 |
Target vessel revascularisation | 27 (27.3%) | 11 (10.7%) | 0.003 |
Primary end points at one year | |||
Death | 18 (18.2%) | 10 (9.7%) | 0.08 |
Reinfarction | 13 (13.1%) | 8 (7.8%) | 0.21 |
Composite (death + reinfarction) | 31 (31.3%) | 18 (17.5%) | 0.022 |
Other cardiac events at one year | |||
Angina | 24 (24.2%) | 20 (19.4%) | 0.41 |
Heart failure | 17 (17.2%) | 22 (21.4%) | 0.45 |
Target vessel revascularisation | 36 (36.4%) | 20 (19.4%) | 0.007 |